Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 801–900 of 1,003
HCSGD: An integrated database of human cellular senescence genes
Dong, Q., Han, H., Liu, X., Wei, L., Zhang, W., Zhao, Z., Zhang, M. Q., & Wang, X. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.001 · Cited by 24
Novitasari, D., Jenie, R. I., Wulandari, F., Utomo, R. Y., Putri, D. D. P., Kato, J., & Meiyanto, E. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00760 · Cited by 23
The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity
Mumcuoğlu, M., Baǧışlar, S., Yuzugullu, H., Alotaibi, H., Şentürk, Ş., Telkoparan‐Akillilar, P., Dedeoğlu, B. G., Cingoz, B., Bozkurt, B., Tazebay, U. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011288 · Cited by 20
BS69 is involved in cellular senescence through the p53–p21Cip1 pathway
Zhang, W., Chan, H. M., Gao, Y., Poon, R. Y. C., & Wu, Z. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401049 · Cited by 22
Knockdown of IL-8 Provoked Premature Senescence of Placenta-Derived Mesenchymal Stem Cells
Li, J., Ma, F., Wang, Y., Chen, F., Lu, S., Chi, Y., Du, W., Song, B., Hu, L., Chen, H., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0324 · Cited by 25
Schmid, G., Kramer, M. P., Maurer‐Granofszky, M., Wandl, S., & Węsierska‐Gądek, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21383 · Cited by 20
The Importance of Satellite Sequence Repression for Genome Stability
Zeller, P. J., & Gasser, S. M. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.033662 · Cited by 24
Tanaka, H., Beam, M. J., & Caruana, K. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.009 · Cited by 19
“In addition, only p53 function is required for the replicative arrest of murine cells but inactivation of both the p53 and p16 pathways are needed for human cells to become malignant [28,29].”
BackgroundWen, Z., Jiang, R., Huang, Y., Wen, Z., Rui, D., Liao, X., & Ling, Z. (2019) · Respiratory Research · doi:10.1186/s12931-019-1165-0 · Cited by 20
Busetto, G. M., Porreca, A., Giudice, F. D., Maggi, M., D’Agostino, D., Romagnoli, D., Musi, G., Lucarelli, G. T., Palmer, K., di Paliano, A. C., et al. (2020) · Urologia Internationalis · doi:10.1159/000509065 · Cited by 19
Huth, H. W., Castro‐Gomes, T., Goes, A. M., & Ropert, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96449-7 · Cited by 20
Hernández‐Mercado, E., Prieto‐Chávez, J. L., Arriaga‐Pizano, L., Hernández-Gutiérrez, S., Mendlovic, F., Königsberg, M., & López‐Díazguerrero, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910215 · Cited by 19
Type 2 diabetes and bone fragility in children and adults
Faienza, M. F., Pontrelli, P., & Brunetti, G. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i11.900 · Cited by 20
Li, Q., Wang, Z., Shi, N., Yang, Q., Yao, W., Yu, J., & Lu, Y. (2023) · Smart Medicine · doi:10.1002/smmd.20230030 · Cited by 20
Parrondo's paradox reveals counterintuitive wins in biology and decision making in society
Wen, T., & Cheong, K. H. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.08.002 · Cited by 22
Telomeres: Unlocking the Mystery of Cell Division and Aging
Zanni, G. R., & Wick, J. Y. (2011) · The Consultant Pharmacist · doi:10.4140/tcp.n.2011.78 · Cited by 22
Cai, J., Qi, H., Yao, K., Yao, Y., Jing, D., Liao, W., & Zhao, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650431 · Cited by 22
Ross, A. L., Sanchez, M. I., & Grichnik, J. M. (2011) · ISRN Dermatology · doi:10.5402/2011/642157 · Cited by 26
Cao, Y., Yang, T., Gu, C., & Ding-hua, Y. (2013) · Cell Biology International · doi:10.1002/cbin.10041 · Cited by 19
Histogenesis of Congenital and Acquired Melanocytic Nevi: A Unifying Concept
Saida, T. (2006) · American Journal of Dermatopathology · doi:10.1097/00000372-200608000-00020 · Cited by 19
Borlon, C., Vankoningsloo, S., Godard, P., Debacq‐Chainiaux, F., & Toussaint, O. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.014 · Cited by 21
Shao, G., Balajee, A. S., Hei, T. K., & Zhao, Y. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20434 · Cited by 22
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Cellular Senescence: A Bridge Between Diabetes and Microangiopathy
Liu, J., Guo, B., Liu, Q., Zhu, G., Wang, Y., Wang, N., Yang, Y., & Fu, S. (2024) · Biomolecules · doi:10.3390/biom14111361 · Cited by 23
Managing Doxorubicin Cardiotoxicity: Insights Into Molecular Mechanisms and Protective Strategies
khafaji, A. T. A., Barakat, A. M., shayyal, A. J., Taan, A. A., & Al-Aouadi, R. F. A. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70155 · Cited by 23
Age-related function of tumor suppressor gene TP53:contribution to cancer risk and progression.
Чердынцева, Н. В., Анатольевна, Г. П., Litvyakov, N. V., Mn, S., Aa, P., Ay, D., Denisov, E. V., Белявская, В. А., & Choĭnzonov, E. L. (2010) · PubMed · Cited by 18
A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass
Liu, X., Wei, L., Dong, Q., Liu, L., Zhang, M. Q., Xie, Z., & Wang, X. (2019) · Aging · doi:10.18632/aging.102034 · Cited by 21
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 20
Ma, Y., Li, S., Ye, S., Hu, D., Wei, L. J., & Xiao, F. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113645 · Cited by 21
Chen, M., Wu, G., Lu, Y., Sun, S., Zhao, Y., Pan, X., Chen, W., Xu, J., Qiu, H., He, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.002 · Cited by 19
Talluri, S., & Dick, F. A. (2013) · Cell Cycle · doi:10.4161/cc.27527 · Cited by 22
Zhang, F., Zakaria, S. M., Tabor, V., Singh, M., Tronnersjö, S., Goodwin, J., Selivanova, G., Bártek, J., Castell, A., & Larsson, L. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1553339 · Cited by 19
Adipose Derived Mesenchymal Stem Cells from a Hypoxic Culture Reduce Cartilage Damage
Wang, J., Liao, Y., Wu, S.-H., Huang, H., Chou, P., & Chiang, E. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10169-z · Cited by 18
Targeting cellular senescence to combat cancer and ageing
Wang, C., Hao, X., & Zhang, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13266 · Cited by 21
The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
Porciuncula, A., Hajdu, C. H., & David, G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.006 · Cited by 20
ERM Proteins and Cdk5 in Cellular Senescence
Yang, H.-S., Alexander, K., Santiago, P., & Hinds, P. W. (2003) · Cell Cycle · doi:10.4161/cc.2.6.582 · Cited by 22
Aging Effects on Cardiac Progenitor Cell Physiology
Rota, M., Goichberg, P., Anversa, P., & Leri, A. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140082 · Cited by 23
Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
Saleh, T., & Carpenter, V. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000361 · Cited by 17
Smith, S. K., & Kipling, D. (2004) · Cytogenetic and Genome Research · doi:10.1159/000078219 · Cited by 22
A structural basis for cellular senescence
Aranda‐Anzaldo, A. (2009) · Aging · doi:10.18632/aging.100074 · Cited by 17
The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
Valenzuela, C. A., Quintanilla, R., Moore‐Carrasco, R., & Brown, N. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00188 · Cited by 18
Sosińska, P., Maćkowiak, B., Staniszewski, R., Sumińska-Jasińska, K., Maj, M., Krasiński, Z., & Bręborowicz, A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488167 · Cited by 17
Eberhardt, K., Matthäus, C., Marthandan, S., Diekmann, S., & Popp, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207380 · Cited by 18
Takeshita, H., Yamamoto, K. I., Mogi, M., Nozato, S., Horiuchi, M., & Rakugi, H. (2019) · Hypertension Research · doi:10.1038/s41440-019-0375-7 · Cited by 17
Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence
Brookes, S., Gagrica, S., Sanij, E., Rowe, J., Gregory, F. J., Hara, E., & Peters, G. G. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1010866 · Cited by 21
Lehmann, B. D., McCubrey, J. A., & Terrian, D. M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.8.4544 · Cited by 19
Naru, E., Takanezawa, Y., Kobayashi, M., Misaki, Y., Kaji, K., & Arakane, K. (2008) · Human Cell · doi:10.1111/j.1749-0774.2008.00052.x · Cited by 18
Maurelli, R., Tinaburri, L., Gangi, F. M., Bondanza, S., Severi, A. L., Scarponi, C., Albanesi, C., Mesiti, G., Guerra, L., Capogrossi, M. C., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.176842 · Cited by 18
Could stress granules be involved in age-related diseases?
Gallouzi, I. (2009) · Aging · doi:10.18632/aging.100090 · Cited by 22
Assessment and consequences of cell senescence in atherosclerosis
Garrido, A. M., & Bennett, M. R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000327 · Cited by 19
Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells
Li, S. G., Yan, M., Zhang, D., Ye, M., & Deng, J. J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038409 · Cited by 17
Mitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer
Balaraman, A. K., Afzal, M., Moglad, E. H. O., Babu, M. A., Priya, G. P., Bansal, P., Rajotiya, S., Kondapavuluri, B. K., Kazmi, I. A., Alzarea, S. I., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10194-2 · Cited by 16
Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise
Hinterleitner, C., Goldberg, H. V., McHugh, D., Barthet, V. J. A., Filliol, A. A., & Lowe, S. W. (2026) · Cell · doi:10.1016/j.cell.2026.03.005 · Cited by 24
Self-citationPersonalized Medicine: Regulation of Genes in Human Skin Ageing
Khorsandi, D., Moghanian, A., & Nazari, R. (2016) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000245 · Cited by 17
Impact of 10‐day bed rest on serum levels of irisin and markers of musculoskeletal metabolism
Oranger, A., Storlino, G., Dicarlo, M., Zerlotin, R., Pignataro, P., Sanesi, L., Narici, M. V., Pišot, R., Šimunič, B., Colaianni, G., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202201005rr · Cited by 20
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Warman, D. J., Jia, H., & Kato, H. (2023) · Antioxidants · doi:10.3390/antiox12061178 · Cited by 17
Skrzeszewski, M., Maciejewska, M., Kobza, D., Gawrylak, A., Kiéda, C., & Waś, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116277 · Cited by 17
Li, J., Qi, X., Lai, M., Zhou, J., Yuan, M., You, J., Liu, Q., Pan, J., Zhao, L., Ying, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2407904121 · Cited by 20
Malavolta, M., Pierpaoli, E., Giacconi, R., Basso, A., Cardelli, M., Piacenza, F., & Provinciali, M. (2018) · Biological Procedures Online · doi:10.1186/s12575-018-0087-4 · Cited by 22
Elimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory
Libertini, G., Ferrara, N., Rengo, G., & Corbi, G. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120064 · Cited by 19
Santos, J. C., Ribeiro, M. L., & Gambero, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.612268 · Cited by 16
Comprehensive Nanorobotic Control of Human Morbidity and Aging
Freitas, R. A. (2010) · The Future of Aging · doi:10.1007/978-90-481-3999-6_23 · Cited by 16
Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence
Ghadaouia, S., Olivier, M., Martinez, A., Kientega, T., Jian, Q., Lambert-Lanteigne, P., Cardin, G. B., Autexier, C., Malaquin, N., & Rodier, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab965 · Cited by 19
Wang, H., Stevens, T., Lu, J. L., Airik, M., Airik, R., & Prochownik, E. V. (2022) · Cells · doi:10.3390/cells11244087 · Cited by 15
Ruiz-Aparicio, P. F., & Vernot, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050716 · Cited by 18
Walen, K. H. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.22023 · Cited by 16
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
Bajbouj, K., Shafarin, J., Taneera, J., & Hamad, M. A. (2020) · Biology · doi:10.3390/biology9040068 · Cited by 16
Palazzo, A., Hernández‐Vargas, H., Goehrig, D., Médard, J., Vindrieux, D., Flaman, J., & Bernard, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215850 · Cited by 17
Senescence program and its reprogramming in pancreatic premalignancy
Yang, K., Li, X., & Xie, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06040-3 · Cited by 21
Targeting Senescent Cells as Therapy for CKD
Mylonas, K. J., & Ferenbach, D. A. (2023) · Kidney360 · doi:10.34067/kid.0000000000000316 · Cited by 23
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity
Jain, S. S., Sojo, G. B., Sun, H., Friedland, B. N., McNamara, M. E., Schmidt, M. O., & Wellstein, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137013 · Cited by 18
Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts
Morettin, A., Ward, A., Nantais, J., & Hudson, J. W. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-319 · Cited by 2
Aging of the inceptive cellular population: the relationship between stem cells and aging
Symonds, C. E., Galderisi, U., & Giordano, A. (2009) · Aging · doi:10.18632/aging.100036 · Cited by 19
Kareva, I. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2016.01.024 · Cited by 16
Liao, G.-Y., Lee, M., Fan, J.-J., Hsiao, P., Lee, C.-S., Su, S.-Y., Hwang, J.-J., & Ke, F. (2019) · Biology Open · doi:10.1242/bio.038257 · Cited by 20
Cellular Senescence: Many Roads, One Final Destination
Saab, R. H. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.68 · Cited by 16
Chitosan delaying human fibroblast senescence through downregulation of TGF-β signaling pathway
Tsai, C.-W., Chiang, I., Wang, J., & Young, T. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1394873 · Cited by 17
Two isomers of HDTIC isolated from Astragali Radix decrease the expression of p16 in 2BS cells
Wang, P., Zhang, Z., Zhang, J., & Tong, T. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200802010-00009 · Cited by 15
Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy
Wang, Y., Wang, L., Wei, Y., Wei, C., Yang, H., Chen, Q., Zhang, R., & Shen, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01049-2 · Cited by 21
p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer
Park, S. S., Lee, Y., Park, S. H., Lim, S. B., Choi, Y. W., Shin, J. S., Kim, Y. H., Kim, J., & Park, T. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13170 · Cited by 17
Dormancy of cutaneous melanoma
Singvogel, K., & Schittek, B. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03278-5 · Cited by 17
Attenuation of ATM signaling by ROS delays replicative senescence at physiological oxygen
Stuart, A., Takai, K., Gabbasova, R. R., Sanford, H., Vinogradova, E. V., & de Lange, T. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.11.006 · Cited by 15
Role of Senescence in Tumorigenesis and Anticancer Therapy
Stoczyńska-Fidelus, E., Węgierska, M., Kierasińska, A., Ciunowicz, D., & Rieske, P. (2022) · Journal of Oncology · doi:10.1155/2022/5969536 · Cited by 15
Zebrafish Models for Skeletal Muscle Senescence: Lessons from Cell Cultures and Rodent Models
Ichii, S., Matsuoka, I., Okazaki, F., & Shimada, Y. (2022) · Molecules · doi:10.3390/molecules27238625 · Cited by 15
Molecular Mechanisms of Cellular Senescence
Becker, T. M., & Haferkamp, S. (2013) · InTech eBooks · doi:10.5772/54120 · Cited by 22
Detection of Oncogene-Induced Senescence In Vivo
Baek, K., & Ryeom, S. W. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_18 · Cited by 15
The Tumor-Immune Response Is Not Compromised by Mesenchymal Stromal Cells in Humanized Mice
Moquin‐Beaudry, G., Colas, C., Li, Y., Bazin, R., Guimond, J. V., Haddad, É., & Beausejour, C. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900807 · Cited by 16
Wurz, G. T., & DeGregorio, M. W. (2014) · International Journal of Cancer · doi:10.1002/ijc.28773 · Cited by 14
Poleszczuk, J., Krzywon, A., Foryś, U., & Wideł, M. (2015) · Radiation Research · doi:10.1667/rr13907.1 · Cited by 16
The senescence pathway in prostatic carcinogenesis
Sharma, S., Shin, J., Grimshaw, M. J., Clarke, R. A., & Lee, C. S. (2010) · Pathology · doi:10.3109/00313025.2010.508791 · Cited by 14
Kang, M., Kim, R. H., Shin, K.-H., Zhong, W., Faull, K. F., & Park, N.-H. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.019 · Cited by 17
Pan-cancer single cell RNA-seq uncovers recurring programs of cellular heterogeneityPreprint
Kinker, G. S., Greenwald, A., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A. C., Rodman, C., Roth, J. A., Bender, S. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/807552 · Cited by 14
Malojirao, V. H., Vasquez, V., Kodavati, M., Mitra, J., Provasek, V., Voh, A. T. T., Liopo, A. V., Derry, P. J., Mikheev, A. M., Rostomily, R. C., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07983-3 · Cited by 13
“Moreover, our investigation revealed the reversible nature of early senescent response to hemin treatment, contrasting with the progression to irreversible senescence observed with prolonged exposure to hemin, characterized by p16 expression, a marker associated with irreversible senescence 40 .”
Cellular senescence and cell therapy in cardiovascular diseases
Chang, D., Wang, J., Zhu, S., Shentu, Y., Wang, Y., Zhu, P., & Ōno, M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04731-6 · Cited by 15
Regulation of cellular senescence by innate immunity
Hou, J., Zheng, Y., & Gao, C. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230032 · Cited by 18
DNA double-strand break repair is impaired in presenescent Syrian hamster fibroblasts
Solovjeva, L., Firsanov, D., Василишина, А. А., Chagin, V. O., Pleskach, N., Kropotov, A., & Svetlova, M. (2015) · BMC Molecular Biology · doi:10.1186/s12867-015-0046-4 · Cited by 13
Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro‐oncogenic phenotype in HNSCC
Gracilla, D. E., Korla, P. K., Lai, M., Chiang, A., Liou, W., & Sheu, J. J. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12806 · Cited by 14
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.